Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data at American Association for Cancer Research (AACR) Annual Meeting

World News: . []

PHILADELPHIA Pa and OXFORD United Kingdom, April 16 2018 GLOBE NEWSWIRE -- Adaptimmune Therapeutics plcNasdaqADAP a leader in T-cell therapy to treat cancer presented two posters summarizing preclinical research with its MAGE-A4 and M AGE-A10...

More news and information about Adaptimmune Therapeutics plc

Published By:

Globe Newswire: 19:00 GMT Monday 16th April 2018

Published: .

Search for other references to "adaptimmune" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us